Terms ending in 2042
Musc Foundation for Research Development
Every in-force patent on Musc Foundation for Research Development's record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,761,224 | AN AGR2Xcd3 BISPECIFIC ENGAGER FOR THE TREATMENT OF CANCER In force · Medium confidence | Musc Foundation for Research Development | In force | Medium confidence | |
| US 12,295,858 | Expandable Vertebral Body Replacement Device and Method In force · High confidence | Musc Foundation for Research Development D/B/A Zucker Institute for Innovation Commercialization | In force | High confidence | |
| US 12,023,330 | Use of Manzamines as Antiproliferative Agent In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 12,390,490 | Sphingolipid-Based Selenium Compounds, Methods for Their Preparation, and Pharmaceutical Uses Thereof, Including as Antitumor Agents In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 12,415,057 | Ultrasound-Based Shunt Flow Detection In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 12,788,590 | Articulating Expandable Device In force · High confidence | MUSC Foundation for Research Development | In force | High confidence | |
| US 12,569,240 | Decorticating Screw In force · High confidence | Musc Foundation for Research Development | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.